Aurinia Pharmaceuticals Stock Analysis

Aurinia Stock Analysis Notes

About 39.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 1.95. Some equities with similar Price to Book (P/B) outperform the market in the long run. Aurinia Pharmaceuticals recorded a loss per share of 0.54. The entity had not issued any dividends in recent years. The firm had 1:50 split on the 23rd of October 2013. Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. It has a collaboration and license agreement with Otsuka Pharmaceutical Co., Ltd. Aurinia Pharm operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 300 people. For more info on Aurinia Pharmaceuticals please contact Stephen Zaruby at 250 744 2487 or go to https://www.auriniapharma.com.

Aurinia Pharmaceuticals Investment Alerts

Aurinia Pharmaceuticals Upcoming and Recent Events

Aurinia Largest EPS Surprises

View All Earnings Estimates

Aurinia Stock Institutional Investors

Note, although Aurinia Pharmaceuticals' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Aurinia Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 739.72 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Aurinia Pharmaceuticals's market, we take the total number of its shares issued and multiply it by Aurinia Pharmaceuticals's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Aurinia Profitablity

The company has Profit Margin (PM) of (0.44) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.53) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.53.

Management Efficiency

Aurinia Pharmaceuticals has return on total asset (ROA) of (0.1052) % which means that it has lost $0.1052 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.1992) %, meaning that it created substantial loss on money invested by shareholders. Aurinia Pharmaceuticals' management efficiency ratios could be used to measure how well Aurinia Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities. The current Return On Tangible Assets is estimated to decrease to -0.15. The current Return On Capital Employed is estimated to decrease to -0.19. As of now, Aurinia Pharmaceuticals' Total Current Assets are increasing as compared to previous years. The Aurinia Pharmaceuticals' current Intangible Assets is estimated to increase to about 7 M, while Net Current Asset Value is forecasted to increase to (8.5 M).

Technical Drivers

As of the 25th of April, Aurinia Pharmaceuticals shows the Mean Deviation of 2.26, standard deviation of 3.9, and Risk Adjusted Performance of (0.09). Aurinia Pharmaceuticals technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We were able to interpolate data for thirteen technical drivers for Aurinia Pharmaceuticals, which can be compared to its peers. Please confirm Aurinia Pharmaceuticals information ratio and potential upside to decide if Aurinia Pharmaceuticals is priced correctly, providing market reflects its regular price of 5.03 per share. Given that Aurinia Pharmaceuticals has information ratio of (0.18), we suggest you to validate Aurinia Pharmaceuticals's prevailing market performance to make sure the company can sustain itself at a future point.

Aurinia Pharmaceuticals Price Movement Analysis

Aurinia Pharmaceuticals Insider Trading Activities

Aurinia Pharmaceuticals Predictive Daily Indicators

Aurinia Pharmaceuticals Corporate Filings

Aurinia Pharmaceuticals Forecast Models

Aurinia Pharmaceuticals' time-series forecasting models are one of many Aurinia Pharmaceuticals' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Aurinia Pharmaceuticals' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Aurinia Pharmaceuticals prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Aurinia shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Aurinia Pharmaceuticals. By using and applying Aurinia Stock analysis, traders can create a robust methodology for identifying Aurinia entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Aurinia analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Aurinia analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Aurinia Pharmaceuticals stock analysis indicators help investors evaluate how Aurinia Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Aurinia Pharmaceuticals shares will generate the highest return on investment. By understating and applying Aurinia Pharmaceuticals stock analysis, traders can identify Aurinia Pharmaceuticals position entry and exit signals to maximize returns.

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aurinia Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey. For more detail on how to invest in Aurinia Stock please use our How to Invest in Aurinia Pharmaceuticals guide.You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.

When running Aurinia Pharmaceuticals' price analysis, check to measure Aurinia Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aurinia Pharmaceuticals is operating at the current time. Most of Aurinia Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Aurinia Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aurinia Pharmaceuticals' price. Additionally, you may evaluate how the addition of Aurinia Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.

Is Aurinia Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aurinia Pharmaceuticals. If investors know Aurinia will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aurinia Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Aurinia Pharmaceuticals is measured differently than its book value, which is the value of Aurinia that is recorded on the company's balance sheet. Investors also form their own opinion of Aurinia Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Aurinia Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aurinia Pharmaceuticals' market value can be influenced by many factors that don't directly affect Aurinia Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Aurinia Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Aurinia Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aurinia Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.